OA13350A - Elemental sulfur as an oral or parentral medical product. - Google Patents

Elemental sulfur as an oral or parentral medical product. Download PDF

Info

Publication number
OA13350A
OA13350A OA1200600213A OA1200600213A OA13350A OA 13350 A OA13350 A OA 13350A OA 1200600213 A OA1200600213 A OA 1200600213A OA 1200600213 A OA1200600213 A OA 1200600213A OA 13350 A OA13350 A OA 13350A
Authority
OA
OAPI
Prior art keywords
ail
éléments
formula
salts
compounds
Prior art date
Application number
OA1200600213A
Other languages
English (en)
Inventor
Ahmed Kotb Abdalla Magd
Original Assignee
Ahmed Kotb Abdalla Magd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ahmed Kotb Abdalla Magd filed Critical Ahmed Kotb Abdalla Magd
Publication of OA13350A publication Critical patent/OA13350A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B30PRESSES
    • B30BPRESSES IN GENERAL
    • B30B5/00Presses characterised by the use of pressing means other than those mentioned in the preceding groups
    • B30B5/02Presses characterised by the use of pressing means other than those mentioned in the preceding groups wherein the pressing means is in the form of a flexible element, e.g. diaphragm, urged by fluid pressure

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Fluid Mechanics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
OA1200600213A 2003-12-23 2004-02-16 Elemental sulfur as an oral or parentral medical product. OA13350A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EG2003121103A EG26569A (en) 2003-12-23 2003-12-23 The element sulfur and its acid formations and derivatives of the enzyme deficiency of the enzyme glutase S transferfrez and epoxide hydrolys for all types of disease associated with this deficiency

Publications (1)

Publication Number Publication Date
OA13350A true OA13350A (en) 2007-04-13

Family

ID=34707229

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200600213A OA13350A (en) 2003-12-23 2004-02-16 Elemental sulfur as an oral or parentral medical product.

Country Status (19)

Country Link
US (1) US20070141176A1 (es)
EP (1) EP1696938A1 (es)
JP (1) JP2007515437A (es)
CN (1) CN1905888A (es)
AP (1) AP2006003663A0 (es)
AU (1) AU2004305184A1 (es)
BR (1) BRPI0418124A (es)
CA (1) CA2551186A1 (es)
EA (1) EA200601208A1 (es)
EG (1) EG26569A (es)
IL (1) IL175617A0 (es)
LT (1) LT5486B (es)
LV (1) LV13492B (es)
MX (1) MXPA06007337A (es)
NO (1) NO20063416L (es)
OA (1) OA13350A (es)
TN (1) TNSN06259A1 (es)
WO (1) WO2005060979A1 (es)
ZA (1) ZA200604886B (es)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4596706A (en) * 1985-04-12 1986-06-24 Elena Avram Method for eliminating or reducing the desire for smoking
WO1989009604A1 (en) * 1988-04-05 1989-10-19 Dale Driver Dietary mineral sulfur supplement
US5716606A (en) * 1995-08-24 1998-02-10 Boyce; Reginald D. Lotion-based sulfur preparation for skin treatment
US6531506B1 (en) * 1996-08-13 2003-03-11 Regents Of The University Of California Inhibitors of epoxide hydrolases for the treatment of hypertension
US6203820B1 (en) * 1998-05-28 2001-03-20 Brice E. Vickery Compositions and methods for enhancing protein anabolism and detoxification
WO2000061154A1 (en) * 1999-04-08 2000-10-19 Khan Airudin S Composition, containing sublimed sulphur, for altering plasma homodyst(e) levels in humans
DE60222899T2 (de) 2001-01-13 2008-08-14 Auburn University, Auburn Verbindungen, verfahren und zusammensetzungen für die behandlung von infektionen mit dem rinderdiarrhö-virus (bvdv) und dem hepatitis-c-virus (hcv)
WO2003037263A2 (en) * 2001-10-29 2003-05-08 Brian Penick Sunspot skin cream

Also Published As

Publication number Publication date
IL175617A0 (en) 2006-09-05
EP1696938A1 (en) 2006-09-06
LT2006062A (lt) 2007-10-25
EA200601208A1 (ru) 2006-12-29
NO20063416L (no) 2006-09-25
LV13492B (en) 2008-04-20
CA2551186A1 (en) 2005-07-07
WO2005060979A8 (en) 2007-01-04
TNSN06259A1 (en) 2007-12-03
JP2007515437A (ja) 2007-06-14
AP2006003663A0 (en) 2006-06-30
CN1905888A (zh) 2007-01-31
KR20070000441A (ko) 2007-01-02
EG26569A (en) 2014-02-23
ZA200604886B (en) 2007-05-30
WO2005060979A1 (en) 2005-07-07
MXPA06007337A (es) 2007-03-01
US20070141176A1 (en) 2007-06-21
BRPI0418124A (pt) 2007-04-17
AU2004305184A1 (en) 2005-07-07
LT5486B (lt) 2008-04-25

Similar Documents

Publication Publication Date Title
JP4334620B2 (ja) ヒアルロン酸の局所麻酔剤との塩からなる医薬品
US4160827A (en) Metronidazole phosphate and salts
CA2340052C (en) Pharmaceutical compositions containing lipase inhibitors and chitosan
RU2706239C2 (ru) Целастрол и его производные для лечения ожирения
EP0147741B1 (de) Pharmazeutische Zubereitung mit speziellen 1,2-Diacyl-Glycero-3-Phosphocholinen zur Behandlung von Erkrankungen im Magen-Darmbereich
EP4082541A1 (en) Compounds for the treatment of obesity and methods of use thereof
JP2002501015A (ja) リーシュマニア症の治療における経口投与のためのミルテフォシンを含有する固形医薬品
SK9492000A3 (en) Pharmaceutical composition containing sibutramine and orlistat
CN1130863A (zh) 含磷酸酯或盐衍生物的组合物
JPH07507288A (ja) デスフェリオキサミン−b塩及び経口的に有効な鉄キレート剤としてのそれらの使用
JPS60120995A (ja) 新規アミノ酸誘導体の製法
CN108697663A (zh) 在肝病治疗中使用胱天蛋白酶抑制剂的方法
PL111746B1 (en) Method of preparing of novel derivatives of amino acids
CN118284615A (zh) 化合物、其外消旋体、它们的盐、组合物、抗炎剂、痴呆症治疗剂及雷特综合征治疗剂
OA13350A (en) Elemental sulfur as an oral or parentral medical product.
JP7566336B2 (ja) カンナビノイド由来組成物の吸収変動を低減するn-アシル化脂肪アミノ酸
US6713513B2 (en) Method for treating cartilage related diseases
KR20060136411A (ko) 경구 또는 비경구 약제로서의 원소 황
KR20200052191A (ko) 후각수용체 특이적 리간드 및 그 용도
EP0797444A1 (fr) Trousse pour cycle de traitement de l'osteoporose
JPH06279432A (ja) 新規な化合物および該化合物を有効成分とする抗癌剤
WO2022072864A2 (en) Stabilization of cannabinoids within solid dosage forms
JP4949224B2 (ja) 薬物除去剤及び薬物除去促進剤
WO2013017977A1 (en) Compositions and methods for the treatment of cancer
WO1988007867A1 (en) Nootropic